The management of patients with mechanical heart valves and intracerebral haemorrhage

Br J Cardiol 2008;15:145–8 Leave a comment
Click any image to enlarge
Authors:

Patients with mechanical prosthetic heart valves require oral anticoagulation to reduce the risk of thromboembolic events, but this can be complicated by anticoagulant-associated intracerebral haemorrhage (ICH). In order to make appropriate decisions about the resumption of anticoagulation in patients with mechanical heart valves and ICH, the risks of further bleeding must be weighed against those of thromboembolic events. There is limited evidence available to guide clinical decision-making in this situation and each case must be assessed individually, ideally with a multi-disciplinary team approach.

Pay to access this premium content £5

The BJC is introducing a small charge for some of its premium content. On purchase you will receive an email to access the article and have a downloadable PDF to keep. The PDF can be downloaded from a button on the sidebar. Please note the purchase of this article is for your personal use only.
By supporting us in this way, you are helping us to deliver high-quality services to healthcare professionals. We will continue to keep the majority of our content free of charge.


You can access this article without logging in.
But don't miss out on the many Benefits of our Membership. Register Now.
Already a member? Login Now.
THERE ARE CURRENTLY NO COMMENTS FOR THIS ARTICLE - LEAVE A COMMENT